Elevated plasma α-defensins in patients with acute exacerbation of fibrotic interstitial pneumonia

Respiratory Medicine

Volumn 109, Issue 2, 2015, Pages 265-271

  Sakamoto, Noriho ^a   Ishimatsu, Yuji ^a   Kakugawa, Tomoyuki ^a   Yura, Hirokazu ^a   Tomonaga, Masaomi ^a   Harada, Tatsuhiko ^a   Nakashima, Shota ^a   Hara, Shintaro ^a   Hara, Atsuko ^a   Ishimoto, Hiroshi ^b   Yatera, Kazuhiro ^b   Mukae, Hiroshi ^b   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Human neutrophil peptide; Idiopathic pulmonary fibrosis; Interstitial lung disease; Microbial peptide

Indexed keywords

ALPHA DEFENSIN; BETA DEFENSIN 2; BIOLOGICAL MARKER; HUMAN NEUTROPHIL PEPTIDE; UNCLASSIFIED DRUG;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; AUTOPSY; BLOOD LEVEL; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROSING ALVEOLITIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUTROPHIL; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; BLOOD; CASE CONTROL STUDY; INTERSTITIAL LUNG DISEASE; METABOLISM; PATHOPHYSIOLOGY;

AGED; ALPHA-DEFENSINS; BIOMARKERS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; NEUTROPHILS;

EID: 84923071975     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2014.12.015     Document Type: Article

References (33)

1. Y. Kondoh, H. Taniguchi, Y. Kawabata, T. Yokoi, K. Suzuki, and K. Takagi Acute exacerbation in idiopathic pulmonary fibrosis. Analysis of clinical and pathologic findings in three cases Chest 103 1993 1808 1812
2. I.N. Park, D.S. Kim, and T.S. Shim Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis Chest 132 2007 214 220
3. Y. Miyazaki, T. Tateishi, T. Akashi, Y. Ohtani, N. Inase, and Y. Yoshizawa Clinical predictors and histologic appearance of acute exacerbations in chronic hypersensitivity pneumonitis Chest 134 2008 1265 1270
4. S. Yamamoto Histopathological features of pulmonary asbestosis with particular emphasis on the comparison with those of usual interstitial pneumonia Osaka City Med J 43 1997 225 242
5. K. Sakamoto, H. Taniguchi, and Y. Kondoh Acute exacerbation of IPF following diagnostic bronchoalveolar lavage procedures Respir Med 106 2012 436 442
6. T. Sato, S. Teramukai, and H. Kondo Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer J Thorac Cardiovasc Surg 147 2014 1604 1611
7. J.S. Lee, J.W. Song, and P.J. Wolters Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis Eur Respir J 39 2012 352 358
8. R. Tachikawa, K. Tomii, and H. Ueda Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic Respir Int Rev Thorac Dis 83 2012 20 27
9. T. Suda, Y. Kaida, and Y. Nakamura Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases Respir Med 103 2009 846 853
10. J.W. Song, S.B. Hong, C.M. Lim, Y. Koh, and D.S. Kim Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome Eur Respir J 37 2011 356 363
11. D.S. Kim, J.H. Park, B.K. Park, J.S. Lee, A.G. Nicholson, and T. Colby Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features Eur Respir J 27 2006 143 150
12. L. Tiitto, R. Bloigu, U. Heiskanen, P. Paakko, V.L. Kinnula, and R. Kaarteenaho-Wiik Relationship between histopathological features and the course of idiopathic pulmonary fibrosis/usual interstitial pneumonia Thorax 61 2006 1091 1095
13. N. Sakamoto, H. Mukae, and T. Fujii Differential effects of alpha- and beta-defensin on cytokine production by cultured human bronchial epithelial cells Am J Physiol Lung Cell Mol Physiol 288 2005 L508 L513
14. J. Aarbiou, K.F. Rabe, and P.S. Hiemstra Role of defensins in inflammatory lung disease Ann Med 34 2002 96 101
15. M. Pazgier, D.M. Hoover, D. Yang, W. Lu, and J. Lubkowski Human beta-defensins. Cellular and molecular life sciences CMLS 63 2006 1294 1313
16. P. Mendez-Samperio Recent advances in the field of antimicrobial peptides in inflammatory diseases Adv Biomed Res 2 2013 50
17. H. Mukae, N. Matsumoto, and J. Ashitani Neutrophil-related cytokines and neutrophil products in bronchoalveolar lavage fluid of a patient with ANCA negative Wegener's granulomatosis Eur Respir J 9 1996 1950 1954
18. H. Mukae, H. Ishimoto, and S. Yanagi Elevated BALF concentrations of alpha- and beta-defensins in patients with pulmonary alveolar proteinosis Respir Med 101 2007 715 721
19. H. Mukae, H. Iiboshi, and M. Nakazato Raised plasma concentrations of alpha-defensins in patients with idiopathic pulmonary fibrosis Thorax 57 2002 623 628
20. S. Yoshioka, H. Mukae, and H. Ishii Alpha-defensin enhances expression of HSP47 and collagen-1 in human lung fibroblasts Life Sci 80 2007 1839 1845
21. M. Amenomori, H. Mukae, and Y. Ishimatsu Differential effects of human neutrophil peptide-1 on growth factor and interleukin-8 production by human lung fibroblasts and epithelial cells Exp Lung Res 36 2010 411 419
22. J. Ashitani, H. Mukae, Y. Arimura, A. Sano, M. Tokojima, and M. Nakazato High concentrations of alpha-defensins in plasma and bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome Life Sci 75 2004 1123 1134
23. H. Zhang, G. Porro, N. Orzech, B. Mullen, M. Liu, and A.S. Slutsky Neutrophil defensins mediate acute inflammatory response and lung dysfunction in dose-related fashion Am J Physiol Lung Cell Mol Physiol 280 2001 L947 L954
24. K. Bdeir, A.A. Higazi, and I. Kulikovskaya Neutrophil alpha-defensins cause lung injury by disrupting the capillary-epithelial barrier Am J Respir Crit Care Med 181 2010 935 946
25. K. Konishi, K.F. Gibson, and K.O. Lindell Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis Am J Respir Crit Care Med 180 2009 167 175
26. J. Ashitani, H. Mukae, T. Hiratsuka, M. Nakazato, K. Kumamoto, and S. Matsukura Plasma and BAL fluid concentrations of antimicrobial peptides in patients with Mycobacterium avium-intracellulare infection Chest 119 2001 1131 1137
27. Y. Arimura, J. Ashitani, and S. Yanagi Elevated serum beta-defensins concentrations in patients with lung cancer Anticancer Res 24 2004 4051 4057
28. T. Hiratsuka, H. Mukae, and H. Iiboshi Increased concentrations of human beta-defensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis Thorax 58 2003 425 430
29. A. Camelo, R. Dunmore, M.A. Sleeman, and D.L. Clarke The epithelium in idiopathic pulmonary fibrosis: breaking the barrier Front Pharmacol 4 2014 173
30. American thoracic Society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. This joint statement of the american thoracic society (ATS), and the european respiratory society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS executive committee, June 2001 Am J Respir Crit Care Med 165 2002 277 304
31. W.D. Travis, U. Costabel, and D.M. Hansell An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias Am J Respir Crit care Med 188 2013 733 748
32. H.R. Collard, B.B. Moore, and K.R. Flaherty Acute exacerbations of idiopathic pulmonary fibrosis Am J Respir Crit care Med 176 2007 636 643
33. S. Hara, H. Ishimoto, and N. Sakamoto Direct hemoperfusion using immobilized polymyxin B in patients with rapidly progressive interstitial pneumonias: a retrospective study Respir Int Rev Thorac Dis 81 2011 107 117